Gandeeva Therapeutics Revenue and Competitors

Location

$40M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Gandeeva Therapeutics's estimated annual revenue is currently $3.8M per year.(i)
  • Gandeeva Therapeutics's estimated revenue per employee is $77,500
  • Gandeeva Therapeutics's total funding is $40M.

Employee Data

  • Gandeeva Therapeutics has 49 Employees.(i)
  • Gandeeva Therapeutics grew their employee count by 20% last year.

Gandeeva Therapeutics's People

NameTitleEmail/Phone
1
Founder and CEO, Gandeeva Therapeutics Inc.Reveal Email/Phone
2
EVP, Drug DiscoveryReveal Email/Phone
3
VP Human ResourcesReveal Email/Phone
4
Chief Financial OfficerReveal Email/Phone
5
DirectorReveal Email/Phone
6
Senior Manager OperationsReveal Email/Phone
7
Corporate Communications ManagerReveal Email/Phone
8
Executive AssistantReveal Email/Phone
9
Associate Director, Business DevelopmentReveal Email/Phone
10
ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.8M4920%$40MN/A
#2
$0.2M20%N/AN/A
#3
$1.6M21-12%N/AN/A
#4
$3.4M2229%N/AN/A
#5
$13.5M875%N/AN/A
#6
$2M268%$89.5MN/A
#7
$2.8M180%N/AN/A
#8
$49.1M31721%N/AN/A
#9
$1.1M70%N/AN/A
#10
$0.8M525%N/AN/A
Add Company

What Is Gandeeva Therapeutics?

Gandeeva Therapeutics Inc. is a rapidly growing biotechnology company located in Vancouver, BC that seeks to harness the transformative power of cryo-EM technology and machine learning to design better drugs. Our methods overcome limitations in the use of X-ray crystallography for drug design and avoid discovery dead ends that can arise from the use of computational docking methods in the absence of experimental validation. Our AI/ML driven workflows enable high throughput structure determination in combination with innovative biochemical methods to explore low-data targets, membrane proteins and protein complexes. Gandeeva seeks to achieve transformative societal impact on public health by revolutionizing drug discovery and by lowering risks of late-stage clinical failures.

keywords:N/A

$40M

Total Funding

49

Number of Employees

$3.8M

Revenue (est)

20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Gandeeva Therapeutics News

2022-04-17 - Gandeeva CEO shares how integrating AI with cryo-electron ...

Gandeeva Therapeutics, founded in 2021, is developing precision imaging solutions with the integration of cryo-electron microscopy (cryo-EM)...

2022-04-13 - Gandeeva Therapeutics Announces Formation of Scientific ...

Gandeeva Therapeutics, a precision biotechnology company harnessing the power of cryogenic electron microscopy (cryo-EM) and machine...

2022-03-22 - Bayer reloads Leaps with €1.3 billion to step up investments in ...

In 2019, Bayer fully acquired BlueRock Therapeutics, ... co-leading the investment rounds of GRObio and Gandeeva Therapeutics.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.5M4929%N/A
#2
$11.4M49N/AN/A
#3
$8.2M49-43%N/A
#4
$9.8M49-31%N/A
#5
$11.4M4911%N/A